Praxis Precision Medicines (NASDAQ: PRAX) revenue
Praxis Precision Medicines reported revenue of $0.0m for fiscal 2025, 100.0% less than in fiscal 2024 ($8.6m).
Praxis Precision Medicines's best year of the last 4 was fiscal 2024.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $0.0m | −100.0% | −$326.2m | — |
| 2024 | $8.6m | +249.5% | −$200.2m | −2,340.3% |
| 2023 | $2.4m | — | −$126.4m | −5,164.4% |
| 2022 | $0.0m | — | −$215.0m | — |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Praxis Precision Medicines revenue compared with its sector
By revenue for its latest fiscal year, Praxis Precision Medicines ranks 414th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Praxis Precision Medicines, −100.0%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 412th | Nkarta | $0.0m | — |
| 413th | Palisade Bio | $0.0m | — |
| 414th | Praxis Precision Medicines | $0.0m | −100.0% |
| 415th | Rocket Pharmaceuticals | $0.0m | — |
| 416th | Revolution Medicines | $0.0m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Praxis Precision Medicines
- How much revenue did Praxis Precision Medicines make in fiscal 2025?
- Praxis Precision Medicines reported revenue of $0.0m for fiscal 2025, compared with $8.6m in fiscal 2024.
- What was the best year for revenue at Praxis Precision Medicines?
- Of its last 4 fiscal years, fiscal 2024, with $8.6m.
- Where does Praxis Precision Medicines rank in its sector by revenue?
- It ranks 414th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Praxis Precision Medicines come from?
- From the annual report (Form 10-K) that Praxis Precision Medicines files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Praxis Precision Medicines files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022. More on Praxis Precision Medicines: the Praxis Precision Medicines page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.